Literature DB >> 11748377

American ginseng transcriptionally activates p21 mRNA in breast cancer cell lines.

R B Duda1, S S Kang, S Y Archer, S Meng, R A Hodin.   

Abstract

American ginseng (AG) has been demonstrated to inhibit breast cancer cell growth in vitro. p21 protein, a universal cell cycle inhibitor, binds cyclin-CDK complexes, an important mechanism in cell cycle regulation. The purpose of this investigation was to determine if AG induces p21 gene expression in hormone sensitive (MCF-7) and insensitive (MDA-MB-231) breast cancer cell lines. Cells grown in steroid stripped medium (SSM) were treated with AG, 17-beta-estradiol (E2), genistein or cycloheximide (CHX). Northern blot analyses were performed using human p21Cip1 and 36B4 cDNA probes. Cell lines were transiently transfected with select mouse p21 CAT reporter constructs, including those lacking a p53 binding site. Cell cycle analyses was performed by FACScan. The results revealed that AG induced p21 mRNA expression in MCF-7 and MDA-MB-231 cells (p=0.0004; p < or =0.0001, respectively). Neither E2 nor genistein alter p21 mRNA expression. CHX, a protein synthesis inhibitor, did not block p21 mRNA expression induced by AG, indicating that p21 is induced as an immediate early gene. AG activated p21 reporter constructs in transfected cells, independent of p53 binding sites. The cell cycle proliferative phase was significantly decreased by AG and increased by E2 (p < or =0.0001). AG may inhibit breast cancer cell growth by transcriptional activation of the p21 gene, independent of p53.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748377      PMCID: PMC3202203          DOI: 10.3346/jkms.2001.16.S.S54

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  5 in total

1.  Chemical and pharmacological studies of saponins with a focus on American ginseng.

Authors:  Chun-Su Yuan; Chong-Zhi Wang; Sheila M Wicks; Lian-Wen Qi
Journal:  J Ginseng Res       Date:  2010-09-01       Impact factor: 6.060

2.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Authors:  Debra L Barton; Heshan Liu; Shaker R Dakhil; Breanna Linquist; Jeff A Sloan; Craig R Nichols; Travis W McGinn; Philip J Stella; Grant R Seeger; Amit Sood; Charles L Loprinzi
Journal:  J Natl Cancer Inst       Date:  2013-07-13       Impact factor: 13.506

3.  Role of cyclin inhibitor protein p21 in the inhibition of HCT116 human colon cancer cell proliferation by American ginseng (Panax quinquefolius) and its constituents.

Authors:  M L King; L L Murphy
Journal:  Phytomedicine       Date:  2009-08-11       Impact factor: 5.340

4.  Inhibitory Effect of Ginseng on Breast Cancer Cell Line Growth Via Up-Regulation of Cyclin Dependent Kinase Inhibitor, p21 and p53

Authors:  Othman A AL Shabanah; Moureq rashed Alotaibi; Salim S Al Rejaie; Ali R Alhoshani; Mashal M Almutairi; Musaad A Alshammari; Mohamed M Hafez
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

5.  Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study.

Authors:  Ping-Ping Bao; Wei Lu; Yong Cui; Ying Zheng; Kai Gu; Zhi Chen; Wei Zheng; Xiao Ou Shu
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.